Clinical studies show that daily supplementation with Setria dramatically increases glutathione levels in cells and tissue
The net result is a molecule that resists enzymatic breakdown considerably better than an unmodified sequence
In fact, in the aforementioned trials most patients received appropriate treatment for HF, including ACE-i or ARBs
Moreover, up to 20% to 40% of patients with vascular pathologies present moderate to intermediate hyperhomocysteinemia
Rakipovski G, Rolin B, Nhr J, Klewe I, Frederiksen KS, Augustin R, Hecksher-Srensen J, Ingvorsen C, Polex-Wolf J, Knudsen LB